Q1 2025 Apollo Hospitals Enterprise Ltd Earnings Call Transcript
Key Points
- Apollo Hospitals Enterprise Ltd (BOM:508869) reported a strong 15% year-on-year revenue growth in its Healthcare Services business, reaching INR2,637 crores.
- The company saw a 17% year-on-year increase in revenue from insurance patients, indicating a growing consumer preference for high-quality providers.
- Occupancy across the group rose to 68%, an increase of 100 basis points year-on-year.
- Apollo HealthCo's revenues grew by 15% year-on-year to INR2,082 crores, with 44 new stores opened this quarter.
- Consolidated EBITDA increased by 33% year-on-year to INR675 crores, with Healthcare Services EBITDA at INR622 crores, showing a 15% growth.
- The election season resulted in lower store expansion due to delays in approvals, impacting growth momentum.
- The digital platform, Apollo 24/7, saw a slower GMV growth of 9% year-on-year, indicating challenges in scaling up.
- Higher medical admissions this quarter led to a lower ARPOB increase of only 2%, affecting overall profitability.
- The company faced increased IT and cybersecurity costs, impacting EBITDA margins by 0.25% to 0.3%.
- There was a significant reduction in digital platform cash losses, but it still stood at INR937 crores, indicating ongoing challenges in achieving profitability.
Ladies and gentlemen, good day and welcome to Apollo Hospitals Limited Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Mayank Vaswani from CDR India. Thank you, and over to you, sir.
Thank you, Nirav. Good afternoon, everyone, and thank you for joining us on this call hosted by Apollo Hospitals to discuss the financial results for the first quarter of financial year 2024-'25, which were announced yesterday. We have with us today the senior management team represented by Mrs. Suneeta Reddy, Managing Director; Mr. Krishnan Akhileswaran, Group CFO; Dr. Madhu Sasidhar, President and CEO of the Hospitals Division; Mr. Madhivanan, CEO of Apollo HealthCo; Mr. Sriram Iyer, CEO of AHLL; Mr. Sanjiv Gupta, CFO of Apollo HealthCo; Mr. Obul Reddy, CFO of the Pharmacy division; and Mr. Ashish Maheshwari, CFO of AHLL.
Before we begin, I would like to mention that some of the statements made in today's discussion may be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
